We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity.
- Authors
Ning, Zhi-Qiang; Li, Zhi-Bin; Newman, Michael J; Shan, Song; Wang, Xin-Hao; Pan, De-Si; Zhang, Jin; Dong, Mei; Du, Xin; Lu, Xian-Ping
- Abstract
Chidamide (CS055/HBI-8000) is a new histone deacetylase (HDAC) inhibitor of the benzamide class currently under clinical development in cancer indications. This study reports the in vitro and in vivo antitumor characteristics of the compound.
- Publication
Cancer chemotherapy and pharmacology, 2012, Vol 69, Issue 4, p901
- ISSN
1432-0843
- Publication type
Journal Article
- DOI
10.1007/s00280-011-1766-x